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Future of Cardiovascular Epidemiology 
• Background 
• Role of  
– cHealth (community) 
– sHealth (social) 
– mHealth (mobile) 
– eHealth (electronic) 
– gHealth (genomic) 
• A synthesis 
 
What has epidemiology done for medical science lately? 
 
Answer: Much but not enough! 
US age-standardized death rates* attributable to cardiovascular diseases, 2000 to 2013.  
Dariush Mozaffarian et al. Circulation. 2016;133:e38-e360 
Copyright © American Heart Association, Inc. All rights reserved. 
1 in 3 adults 
CVD Risk Factors in US: 2016 
Gap in life expectancy in US of up to 14 years 
US age-standardized death rates* attributable to cardiovascular disease (CVD) by 
race/ethnicity, 2000 to 2013.  
Dariush Mozaffarian et al. Circulation. 2016;133:e38-e360 
Copyright © American Heart Association, Inc. All rights reserved. 
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Chetty R. JAMA 2016 April. 
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 https://www-01.ibm.com/software/data/bigdata/ 
Biosensing  Wearables 
mHealth: personally generated health data (PGHD) 
mHealth/quantitative sensor data 
• wrist-based accelerometers in the Centers for Disease 
Control and Prevention National Health and Nutrition 
Examination Survey (NHANES) and the UK Biobank 
• Health eHeart Study (a PCORnet Patient Powered 
Research Network) 
• Apple’s ResearchKit, MyHeart Counts 
• Extensive “physiome” data through wearable sensors 
are planned for a Baseline Study coordinated by 
Stanford, Duke University, and Google Inc 
• mobile health data also planned for the NIH's Precision 
Medicine Initiative cohort 
mHealth Advantages/Opportunities 
• new knowledge about living with and 
managing health and illness.  
• Increase compliance with meds 
• ‘hovering’ to promote healthy behavior 
• Use predictive analytics and behavioral 
economics 
mHealth: Pitfalls & Challenges 
• Few measurements from wearable sensors have been 
validated relative to existing metrics 
• continuous ambulatory data that do not directly match 
the tests done in the clinic 
• data quality can be dependent on individual 
participants and their level of engagement 
• accepting trade-offs in precision for more frequent, 
scalable measures 
• selection bias from the participants who “opt in” and 
who have sufficient technological knowledge and 
access 
• privacy and security of the data are critical 
mHealth: Pitfalls and Challenges 
• Technology necessary but not sufficient to 
induce health choice 
• Adherence to use of mhealth technology 
unclear 
• Must be integrated into clinical practice 
• Applicability of approaches across diverse 
populations unknown 
• Reach people when they are not patients 
Future of Cardiovascular Epidemiology 
• Background 
• Role of  
– cHealth (community) 
– sHealth (social) 
– mHealth (mobile) 
– eHealth (electronic) 
– gHealth (genomic) 
• A synthesis 
 
http://ww2.kqed.org/science/2014/09/29/how-big-data-is-changing-medicine/ 
How Big Data will change science 
Big Data: EMR 
• Enactment of the Patient Protection and Affordable 
Care Act of 2010  hospitals and clinics received a 
mandate for electronic medical records (EMRs).  
• Digitization of patients’ past histories & complaints, 
treatments, and outcomes  clinical research  
• Lack of standardized data elements and definitions 
limits interoperability  
• National standards have been promulgated, and 
EMRs are slowly mapping to these standards.  
Big Data: EMR 
• Infrastructure projects such as the National Institutes 
of Health (NIH) Collaboratory and the National 
Patient-Centered Clinical Research Network 
(PCORnet) facilitated linking of EMR data across 
multiple large heath systems  
• Large-scale post-market surveillance studies  
• Recruit patients and collect information in practical 
clinical trials 
• Incorporate quality improvement systems into the 
flow of clinical care. 
PCORnet: clinical research and patient engagement on a large scale.  
Elliott M. Antman et al. J Am Heart Assoc 2015;4:e002810 
CDRNs indicates Clinical Data Research Networks;  
PCORI, Patient‐Centered Outcomes Research Institute;  
PCORnet, National Patient‐Centered Clinical Research Network;  
PPRNs, Patient Powered Research Networks. 
 
Growth of Big Data in Health Care 
 
Goals of Big Data Science in Medicine 
Facilitating discovery science: avoiding duplication, ensuring 
reproducibility 
Increasing understanding of human disease 
Improving the design, efficiency, and quality of clinical trials 
Improving the quality of care in clinical settings 
Increasing the effectiveness of prevention 
Translation to public 
Kinds of big data in Medicine 
 
JAMA. 2014;312(19):1969-1970. doi:10.1001/jama.2014.15224 

Challenges 
 
•  integrating large data sets, but it is imperative 
that this is not uncoupled from biological 
investigation  
• Longitudinal datasets: connect the large clinical 
data sets with an abundance of preclinical data,  
 
•  pharma companies externalizing and partnering 
on research  
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Big data: The $1000 Genome 
Big Data in Genomics Era 
 
• deCODE Genetics: history records with 
genome data from 150,000 Icelandic people 
(including 15,000 whole-genome sequences).   
• United Kingdom launched the 100,000 
Genomes Project  
• Geisinger-Regeneron collaboration launched 
250,000 genomes 
• PMI (US) and BGI (China): 1,000,000 genomes 

Precision Medicine 
• Better taxonomy of disease 
• Better ontology of phenome 
• Better predictive & prognostic biomarkers 
• Multidimensional phenotypic/omic data 
• Machine learning 
• Better disease modeling, trajectory and time 
series 
• Data lakes 
Precision Medicine 
• Requires an understanding of the precise relationship 
between gene and phenotype, and the stratification of 
diseases into subtypes according to their underlying 
biological mechanisms  
• Functions of most genes unknown, and what is known limited 
to a few cell types, tissues or physiological contexts.  
• Descriptions of disease phenotypes often fail to capture the 
diverse manifestations of common diseases or to define 
subclasses of those diseases that predict the outcome or 
response to treatment.  
– Phenotype descriptions are typically “sloppy or imprecise”  

Challenges for PMI 
 
Concept of Deep Phenotyping 
•  exhaustive examination of the discrete 
components of a phenotype that goes beyond 
what is typically recorded in medical charts  
•  There are a hundred ways to be “diabetic” 
involving different processes in the pancreas, 
liver, muscle, brain and fat  
•  Genetic studies lose statistical power by 
looking at a conglomeration of underlying 
causes. 
Concept of Deep Phenotyping 
• Different genes are responsible for particular 
subtypes of diabetes, so mixing them together 
obscures the reasons why people with the 
same genetic mutation respond differently to 
the same treatment  
• studying ‘outbred’ mice better mirrors human 
diversity in diseases such as diabetes that 
have many genetic contributors.  
Concept of Deep Phenotyping 
• New human cell models of complex diseases. 
• induce skin cells to form stem cells, and can 
differentiate them into self-assembled clusters 
of cells called organoids, so they can study the 
connections between phenotypes, genomics 
and related biological data  
 
Genomic Big Data 
• Harvesting genomes or even exomes at the 
population scale produces a vast amount of 
data, perhaps up to 40 petabytes (40 million 
gigabytes) each year  
• Storage is not a problem 
• Computational scales increase linearly 
• Processing power is a limiting factor: no 
longer a desk top game! 
• Cloud based architecture and hosting 
Sharing Genomic Big Data 
• A multinational coalition, the Global Alliance 
for Genomics and Health, developed the 
Framework for Responsible Sharing of 
Genomic and Health-Related Data.  
• The Framework includes guidelines on privacy 
and consent, & on accountability and legal 
consequences for those who break the rules.  
• Data-transfer agreements  
Integrating genomics into electronic 
health records  
• The NIH launched the Electronic Medical Records 
and Genomics (eMERGE) Network in 2007 to 
define best practices  
• The issue there is, how do you take a practitioner 
who has 12 minutes per patient and about 45 
seconds of time allocated for prescribing drugs, 
and influence their practice in a meaningful 
way?”  
• Genome is only part of story…other omes! 
• Each patient may become a big-data producer  

PheWAS 
 
 
 
Principles of engagement in federated 
networks 
• Transparency 
• Representation 
• Local benefit 
• Right to reassort 
• Cost neutrality 
• Access 
• Parsimony of 
data storage 
standards 
Cloud Computing 
• access a shared pool of data in an environment 
equipped with extensive and elastic computing 
resources and a sophisticated model for access control 
• allows researchers to rent a data center under a 
pay‐as‐you‐go model 
• also a paradigm for writing algorithms to enable 
massive parallelization, allowing for scalable 
on‐demand “supercomputers.”  
• Because genomic computations are easily parallelized 
by genomic locus, they are ideally suited 
Computational health care 
• 60% of data are exogenous (eg, behavioral, 
socioeconomic, environmental) and are rarely captured 
as part of EMR systems. 
• data are generated in uncontrolled environments (ie, 
no hospital or supply-side control), which create highly 
fragmented value chains that need a neutral entity that 
can collect, store, manage, curate, and analyze data for 
insights 
• To implement behavior modification in clinical care, it 
will be important to study the biometrics, medication 
usage patterns, stress levels, sleep patterns, and 
social interactions of individual patients 
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Paul W. Franks et al. Dia Care 2013;36:1413-1421 
©2013 by American Diabetes Association 
Elliott M. Antman et al. J Am Heart Assoc 2015;4:e002810 
Future of CV Epidemiology: Summing up 
Big Data & Information Overload 
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Knowledge 
Clinical Utility 
Gap 
Gap 
Gap 
“It’s hard to tell who’s swimming naked until the tide goes out.” 
    Warren Buffet 
What has epidemiology done for medical science lately? 
 
Answer: much but not enough! 
 
 
Suggests: 
1. Refocused scientific questions 
2. Centralized and integrated governance 
3. Different types of exposures and outcome measures 
4. Embedded clinical and policy trials 
Disease Mx and Behavior Change? 
• Opportunities to improve disease management 
and treatment may exist through context-aware 
data acquisition, medication/dosage and 
comorbidity management, and patient education 
and engagement 
• behavior change and prevention can be 
addressed by using behavior models to develop 
recommendation services and by understanding 
habit-formation cycles to design new service 
models, incentives, and touch-point 
modifications 
Personalized Medicine vs. 
Personalized Health Care 

Thank You! 
